Cargando…
Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs
BACKGROUND: Fatal drug overdoses in the USA hit historical records during the COVID-19 pandemic. Throughout the pandemic, people who used drugs had greater odds of contracting COVID-19, increased drug use due to COVID-related stress, and heightened levels of anxiety and depression. This qualitative...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250267/ https://www.ncbi.nlm.nih.gov/pubmed/35780109 http://dx.doi.org/10.1186/s12954-022-00653-1 |
_version_ | 1784739774781718528 |
---|---|
author | Conway, Fiona N. Samora, Jake Brinkley, Katlyn Jeong, Haelim Clinton, Nina Claborn, Kasey R. |
author_facet | Conway, Fiona N. Samora, Jake Brinkley, Katlyn Jeong, Haelim Clinton, Nina Claborn, Kasey R. |
author_sort | Conway, Fiona N. |
collection | PubMed |
description | BACKGROUND: Fatal drug overdoses in the USA hit historical records during the COVID-19 pandemic. Throughout the pandemic, people who used drugs had greater odds of contracting COVID-19, increased drug use due to COVID-related stress, and heightened levels of anxiety and depression. This qualitative study examined the specific ways the pandemic negatively impacted people who use drugs. METHODS: Qualitative interviews with 24 people who use drugs and 20 substance use harm reduction workers were conducted. Data from the qualitative interviews were analyzed using applied thematic analysis to identify emergent themes based on the a priori research goals. RESULTS: Thematic analysis identified several common experiences during the pandemic among people who use drugs. These included mental distress due to financial strain and social isolation; increased drug use; increased risky drug-seeking and use behaviors due to changes in the drug markets; and reduced access to harm reduction, treatment, and recovery support services. CONCLUSIONS: Our study highlighted critical systemic failures that contributed to the rise in overdose deaths during the COVID-19 pandemic. Addressing these challenges through policy reform and improved funding models will ensure the sustainability of harm reduction services and increase access to substance use treatment among highly vulnerable people who use drugs. |
format | Online Article Text |
id | pubmed-9250267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92502672022-07-03 Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs Conway, Fiona N. Samora, Jake Brinkley, Katlyn Jeong, Haelim Clinton, Nina Claborn, Kasey R. Harm Reduct J Research BACKGROUND: Fatal drug overdoses in the USA hit historical records during the COVID-19 pandemic. Throughout the pandemic, people who used drugs had greater odds of contracting COVID-19, increased drug use due to COVID-related stress, and heightened levels of anxiety and depression. This qualitative study examined the specific ways the pandemic negatively impacted people who use drugs. METHODS: Qualitative interviews with 24 people who use drugs and 20 substance use harm reduction workers were conducted. Data from the qualitative interviews were analyzed using applied thematic analysis to identify emergent themes based on the a priori research goals. RESULTS: Thematic analysis identified several common experiences during the pandemic among people who use drugs. These included mental distress due to financial strain and social isolation; increased drug use; increased risky drug-seeking and use behaviors due to changes in the drug markets; and reduced access to harm reduction, treatment, and recovery support services. CONCLUSIONS: Our study highlighted critical systemic failures that contributed to the rise in overdose deaths during the COVID-19 pandemic. Addressing these challenges through policy reform and improved funding models will ensure the sustainability of harm reduction services and increase access to substance use treatment among highly vulnerable people who use drugs. BioMed Central 2022-07-02 /pmc/articles/PMC9250267/ /pubmed/35780109 http://dx.doi.org/10.1186/s12954-022-00653-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Conway, Fiona N. Samora, Jake Brinkley, Katlyn Jeong, Haelim Clinton, Nina Claborn, Kasey R. Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs |
title | Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs |
title_full | Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs |
title_fullStr | Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs |
title_full_unstemmed | Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs |
title_short | Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs |
title_sort | impact of covid-19 among people who use drugs: a qualitative study with harm reduction workers and people who use drugs |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250267/ https://www.ncbi.nlm.nih.gov/pubmed/35780109 http://dx.doi.org/10.1186/s12954-022-00653-1 |
work_keys_str_mv | AT conwayfionan impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs AT samorajake impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs AT brinkleykatlyn impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs AT jeonghaelim impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs AT clintonnina impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs AT clabornkaseyr impactofcovid19amongpeoplewhousedrugsaqualitativestudywithharmreductionworkersandpeoplewhousedrugs |